Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Blocking certain proteins on immune cells may help treat alopecia areata.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Dupilumab can both heal and cause hair loss.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

Upadacitinib effectively treats pyoderma gangrenosum.

Mitochondrial stress can lead to atopic dermatitis.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Adalimumab improved folliculitis decalvans in most patients.

Candida antigen is an effective and promising treatment for alopecia areata.